[1] [1] Triantafyllou K, Chang C, Pimentel M.Methanogens, methane and gastrointestinal motility[J]. J Neurogastroenterol Motil, 2014, 20(1): 31-40.

[2] [2] Sahakian AB, Jee SR, Pimentel M. Methane and the gastrointestinal tract[J]. Dig Dis Sci, 2010, 55(8): 2135-2143.

[3] [3] Jones WJ, Nagle DP Jr, Whitman WB.Methanogensand the diversity ofarchaebacteria[J]. Microbiol Rev, 1987, 51(1): 135-177.

[4] [4] Kim G, Deepinder F, Morales W, et al.Methanobrevibacter smithiiis the predominantmethanogenin patients with constipation-predominant IBS and methane on breath[J]. Dig Dis Sci, 2012, 57(12): 3213-3218.

[5] [5] Miller TL, Wolin MJ.Methanosphaera stadtmaniaegen. nov., sp. nov.: a species that forms methane by reducing methanol with hydrogen[J]. Arch Microbiol, 1985, 141(2): 116-122.

[6] [6] Dridi B, Fardeau ML, Ollivier B, et al.Methanomassiliicoccus luminyensisgen. nov., sp. nov., amethanogenic archaeonisolated from human faeces[J]. Int J Syst Evol Microbiol, 2012, 62(Pt 8): 1902-1907.

[7] [7] Ghoshal U, Shukla R, Srivastava D, et al. Irritable bowel syndrome, particularly the constipation-predominant form, involves an increase inmethanobrevibacter smithii, which is associated with higher methane production[J]. Gut Liver, 2016, 10(6): 932-938.

[8] [8] Villanueva-Millan MJ, Leite G, Wang J, et al.Methanogensand hydrogen sulfide producing bacteria guide distinct gut microbe profiles and irritable bowel syndrome subtypes[J]. Am J Gastroenterol, 2022, 117(12): 2055-2066.

[9] [9] Bond JH Jr, Engel RR, Levitt MD. Factors influencing pulmonary methane excretion in man. An indirect method of studying the in situ metabolism of the methane-producing colonic bacteria[J]. J Exp Med, 1971, 133(3): 572-588.

[10] [10] Flouri B, Etanchaud F, Florent C, et al. Comparative study of hydrogen and methane production in the human colon using caecal and faecal homogenates[J]. Gut, 1990, 31(6): 684-685.

[11] [11] Lepp PW, Brinig MM, Ouverney CC, et al.Methanogenic Archaeaand human periodontal disease[J]. Proc Natl Acad Sci U S A, 2004, 101(16): 6176-6181.

[12] [12] Belay N, Mukhopadhyay B, Conway de Macario E, et al.Methanogenic bacteriain human vaginal samples[J]. J Clin Microbiol, 1990, 28(7): 1666-1668.

[13] [13] Gasbarrini A, Corazza GR, Gasbarrini G, et al. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference[J]. Aliment Pharmacol Ther, 2009, 29 Suppl 1: 1-49.

[14] [14] Lawrence NS. Analytical detection methodologies for methane and related hydrocarbons[J]. Talanta, 2006, 69(2): 385-392.

[15] [15] de Lacy Costello BP, Ledochowski M, Ratcliffe NM. The importance of methane breath testing: a review[J]. J Breath Res, 2013, 7(2): 024001.

[16] [16] Weaver GA, Krause JA, Miller TL, et al. Incidence ofmethanogenic bacteriain a sigmoidoscopy population: an association ofmethanogenic bacteriaand diverticulosis[J]. Gut, 1986, 27(6): 698-704.

[17] [17] Kumpitsch C, Fischmeister FPS, Mahnert A, et al. Reduced B12 uptake and increased gastrointestinal formate are associated with archaeome-mediated breath methane emission in humans[J]. Microbiome, 2021, 9(1): 193.

[18] [18] Di Stefano M, Mengoli C, Bergonzi M, et al. Breath methane excretion is not an accurate marker of colonic methane production in irritable bowel syndrome[J]. Am J Gastroenterol, 2015, 110(6): 891-898.

[19] [19] Kunkel D, Basseri RJ, Makhani MD, et al. Methane on breath testing is associated with constipation: a systematic review and meta-analysis[J]. Dig Dis Sci, 2011, 56(6): 1612-1618.

[20] [20] Shah A, Talley NJ, Jones M, et al. Small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis of case-control studies[J]. Am J Gastroenterol, 2020, 115(2): 190-201.

[21] [21] Hwang L, Low K, Khoshini R, et al. Evaluating breath methane as a diagnostic test for constipation-predominant IBS[J]. Dig Dis Sci, 2010, 55(2): 398-403.

[22] [22] Chatterjee S, Park S, Low K, et al. The degree of breath methane production in IBS correlates with the severity of constipation[J]. Am J Gastroenterol, 2007, 102(4): 837-841

[23] [23] Takakura W, Pimentel M, Rao S, et al. A Single fasting exhaled methane level correlates with fecal methanogen load, clinical symptoms and accurately detects intestinal methanogen overgrowth[J]. Am J Gastroenterol, 2022, 117(3): 470-477.

[24] [24] Villanueva-Millan MJ, Leite G, Morales W, et al. Hydrogen sulfide producers drive a diarrhea-like phenotype and a methane producer drives a constipation-like phenotype in animal models[J]. Dig Dis Sci, 2024, 69(2): 426-436.

[25] [25] Attaluri A, Jackson M, Valestin J, et al.Methanogenic florais associated with altered colonic transit but not stool characteristics in constipation without IBS[J]. Am J Gastroenterol, 2010, 105(6): 1407-1411.

[26] [26] Singh P, Duehren S, Katon J, et al. Breath methane does not correlate with constipation severity or bloating in patients with constipation[J]. J Clin Gastroenterol, 2020, 54(4): 365-369.

[27] [27] Cloarec D, Bornet F, Gouilloud S, et al. Breath hydrogen response to lactulose in healthy subjects: relationship to methane producing status[J]. Gut, 1990, 31(3): 300-304.

[28] [28] Morken MH, Berstad AE, Nysaeter G, et al. Intestinal gas in plain abdominal radiographs does not correlate with symptoms after lactulose challenge[J]. Eur J Gastroenterol Hepatol, 2007, 19(7): 589-593.

[29] [29] Pimentel M, Lin HC, Enayati P, et al. Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity[J]. Am J Physiol Gastrointest Liver Physiol, 2006, 290(6): G1089-G1095.

[30] [30] Jahng J, Jung IS, Choi EJ, et al. The effects of methane and hydrogen gases produced by enteric bacteria on ileal motility and colonic transit time[J]. Neurogastroenterol Motil, 2012, 24(2): 185-192, e92.

[31] [31] Pimentel M, Kong Y, Park S. IBS subjects with methane on lactulose breath test have lower postprandial serotonin levels than subjects with hydrogen[J]. Dig Dis Sci, 2004, 49(1): 84-87.

[32] [32] Chojnacki J, Popawski T, Kaczka A, et al. Assessment of urinary dopamine and serotonin metabolites in relation to dysbiosis indicators in patients with functional constipation[J]. Nutrients, 2024, 16(17): 2981.

[33] [33] Pimentel M, Chatterjee S, Chow EJ, et al. Neomycin improves constipation-predominant irritable bowel syndrome in a fashion that is dependent on the presence of methane gas: subanalysis of a double-blind randomized controlled study[J]. Dig Dis Sci, 2006, 51(8): 1297-1301.

[34] [34] Ghoshal UC, Srivastava D, Misra A. A randomized double-blind placebo-controlled trial showing rifaximin to improve constipation by reducing methane production and accelerating colon transit: A pilot study[J]. Indian J Gastroenterol, 2018, 37(5): 416-423.

[35] [35] Low K, Hwang L, Hua J, et al. A combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patients with methane on lactulose breath test[J]. J Clin Gastroenterol, 2010, 44(8): 547-550.

[36] [36] Pimentel M, Chang C, Chua KS, et al. Antibiotic treatment of constipation-predominant irritable bowel syndrome[J]. Dig Dis Sci, 2014, 59(6): 1278-1285.

[37] [37] Gottlieb K, Wacher V, Sliman J, et al. Review article: inhibition ofmethanogenic archaeaby statins as a targeted management strategy for constipation and related disorders[J]. Aliment Pharmacol Ther, 2016, 43(2): 197-212.

[38] [38] Muskal SM, Sliman J, Kokai-Kun J, et al. Lovastatin lactone may improve irritable bowel syndrome with constipation (IBS-C) by inhibiting enzymes in the archaeal methanogenesis pathway[J]. F1000Res, 2016, 5: 606.

[39] [39] Miller TL, Wolin MJ. Inhibition of growth ofmethane-producing bacteriaof the ruminant forestomach by hydroxymethylglutaryl-SCoA reductase inhibitors[J]. J Dairy Sci, 2001, 84(6): 1445-1448.